Coronavirus: Oxford University Begins Human Test on Thursday

Britain is gearing up to develop a communicative vaccine to the new coronary, evidence for which Oxford University scientists will begin Thursday. The British government will invest only in clinical trials of this 20 million-pound vaccine. The number of victims increased in the country, compared with the data [...]
Evidence to man for a communicative vaccine to Ovid-19 will begin on Thursday by Oxford University scientists, Health Secretary Matt Hancock announced.
“I'm sure we'll put everything in perspective to develop a vaccine. The UK has invested more money than any other country in this field,” Hancock said, while adding that the projects in this direction are hopeful and are progressing quickly, both at Oxford University and London College.
The British government will invest 20 million pounds in the Oxford University project to finance clinical trials.
Britain aims to have about one million doses of vaccines ready by September, despite the final result.
Meanwhile, authorities again reported an increase in the number of veins from the coronary. In 24 hours, 823 more victims were reported, while positive news came from London, where the epidemic passed the peak last week and has now begun to decline.












